The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Antimicrobial activity of biosilver nanoparticles produced by a novel Streptacidiphilus durhamensis strain
Open accessAbstract
BACKGROUND/PURPOSE: In this study, an acidophilic actinobacteria strain was used as a novel reducing agent for a single-step synthesis of nanostructure silver particles. We used a Streptacidiphilus durhamensis HGG16n isolate for efficient synthesis of bioactive silver nanoparticles [bio(AgNPs)] in an inexpensive, eco-friendly, and nontoxic manner. The obtained bio(AgNPs) exhibited unique physicochemical and biochemical properties. METHODS: Structural, morphological, and optical properties of the synthesized biocolloids were characterized by spectroscopy, dynamic light scattering, and electron microscopy approaches. The antimicrobial activity was evaluated using the well- and disc-diffusion methods. RESULTS: The obtained crystalline structure and stable biosynthesized silver nanoparticles ranged in size from 8 nm to 48 nm and were mostly spherical in shape. Antimicrobial assays of the silver nanoparticles against pathogenic bacteria showed the highest antimicrobial activity against Pseudomonas aeruginosa, Staphylococcus aureus, and Proteus mirabilis, followed by Escherichia coli, Klebsiella pneumoniae, and Bacillus subtilis. Moreover, the synergistic effect of bio(AgNPs) with various commercially available antibiotics was also evaluated. CONCLUSION: These results provide insight into the development of new antimicrobial agents along with synergistic enhancement of the antibacterial mechanism against clinical bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
Cited by
Salem, S. S., & Fouda, A. (2021) · Biological Trace Element Research · doi:10.1007/s12011-020-02138-3 · Cited by 1,222
Roy, A., Bulut, O., Some, S., Mandal, A. K., & Yilmaz, M. D. (2019) · RSC Advances · doi:10.1039/c8ra08982e · Cited by 1,059
Godoy-Gallardo, M., Eckhard, U., Delgado, L. M., de Roo Puente, Y. J. D., Hoyos-Nogués, M., Gil, F. J., & Perez, R. A. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.033 · Cited by 857
Chandrakala, V., Aruna, V., & Angajala, G. (2022) · Emergent Materials · doi:10.1007/s42247-021-00335-x · Cited by 768
Zinc oxide nanoparticles: Synthesis, antiseptic activity and toxicity mechanism
Król, A., Pomastowski, P., Rafińska, K., Railean-Plugaru, V., & Buszewski, B. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.07.033 · Cited by 731
Self-citationA review on the biosynthesis of metal and metal salt nanoparticles by microbes
Gahlawat, G., & Choudhury, A. R. (2019) · RSC Advances · doi:10.1039/c8ra10483b · Cited by 706
Khan, Y., Sadia, H., Ali Shah, S. Z., Khan, M. N., Shah, A. A., Ullah, N., Ullah, M. F., Bibi, H., Bafakeeh, O. T., Khedher, N. B., et al. (2022) · Catalysts · doi:10.3390/catal12111386 · Cited by 664
Silver Nanoparticles: Mechanism of Action and Probable Bio-Application
Mikhailova, E. O. (2020) · Journal of Functional Biomaterials · doi:10.3390/jfb11040084 · Cited by 621
Synthesis of Silver Nanoparticles and their Biomedical Applications - A Comprehensive Review
Shanmuganathan, R., Karuppusamy, I., Saravanan, M., Muthukumar, H., Ponnuchamy, K., Ramkumar, V. S., & Pugazhendhi, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190708185506 · Cited by 282
Lahiri, D., Nag, M., Sheikh, H. I., Sarkar, T., Edinur, H. A., Pati, S., & Ray, R. R. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.636588 · Cited by 279
Metadata
- Authors
- Buszewski, B., Railean-Plugaru, V., Pomastowski, P., Rafińska, K., Szultka-Mlynska, M., Golinska, P., Wypij, M., Laskowski, D., & Dahm, H.
- Venue
- Journal of Microbiology, Immunology and Infection
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 51
- Issue
- 1
- Pages
- 45-54
- ISSN
- 1684-1182 (ISSN-L)
- OpenAlex
- W2325561486
- Cited by
- 226
- References
- 1
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.